Mechanisms of antidepressant resistance

W El-Hage, S Leman, V Camus… - Frontiers in …, 2013 - frontiersin.org
Depression is one of the most frequent and severe mental disorder. Since the discovery of
antidepressant (AD) properties of the imipramine and then after of other tricyclic compounds …

Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters

B Haenisch, H Bönisch - Pharmacology & therapeutics, 2011 - Elsevier
Major depressive disorder (MDD) which is supposed to result from a complex interaction of
genetic and epigenetic, environmental and developmental factors is one of the most …

International union of basic and clinical pharmacology CIV: the neurobiology of treatment-resistant depression: from antidepressant classifications to novel …

F Caraci, F Calabrese, R Molteni, L Bartova… - Pharmacological …, 2018 - ASPET
Major depressive disorder is one of the most prevalent and life-threatening forms of mental
illnesses and a major cause of morbidity worldwide. Currently available antidepressants are …

New views on antidepressant action

A Baudry, S Mouillet-Richard, JM Launay… - Current opinion in …, 2011 - Elsevier
The increasing incidence of depressive spectrum disorders worldwide, together with the
failure of current medication to effectively treat a significant proportion of cases, calls for a …

The mechanisms of tolerance in antidepressant action

GA Fava, E Offidani - Progress in Neuro-Psychopharmacology and …, 2011 - Elsevier
There is increasing awareness that, in some cases, long-term use of antidepressant drugs
(AD) may enhance the biochemical vulnerability to depression and worsen its long-term …

Mechanisms underlying the antidepressant response and treatment resistance

MR Levinstein, BA Samuels - Frontiers in behavioral neuroscience, 2014 - frontiersin.org
Depression is a complex and heterogeneous disorder affecting millions of Americans. There
are several different medications and other treatments that are available and effective for …

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

C Fabbri, C Crisafulli, R Calati, D Albani… - European archives of …, 2017 - Springer
Genes belonging to neuroplasticity, monoamine, circadian rhythm, and transcription factor
pathways were investigated as modulators of antidepressant efficacy. The present study …

Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder

GI Papakostas, DF Ionescu - Molecular psychiatry, 2015 - nature.com
Depression is a devastating disorder that places a significant burden on both the individual
and society. As such, the discovery of novel therapeutics and innovative treatments …

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment

C Fabbri, S Porcelli, A Serretti - The Canadian Journal of …, 2014 - journals.sagepub.com
Objective: Major depressive disorder is the most common psychiatric disorder, worldwide,
yet response and remission rates are still unsatisfactory. The identification of genetic …

How do antidepressants work? New perspectives for refining future treatment approaches

CJ Harmer, RS Duman, PJ Cowen - The Lancet Psychiatry, 2017 - thelancet.com
Most currently available antidepressants target monoamine neurotransmitter function.
However, a purely neurotransmitter-based explanation for antidepressant drug action is …